Explorer les evidences

Palier Gold : evidences validées mécaniquement, avec leur source primaire.

26 evidences · page 1 / 2

1,51 odds_ratioEarly sexual activity is associated with increased odds of HIV seropositivity in young women (OR = 1.510; 95% CI = 1.100, 2.072).

Burkina FasoVIH/sidapublié 2021Journal of global healthPubMeddocument de 4 observations

58,8 %The most common HIV-1 circulating recombinant forms and subtypes in Burkina Faso were CRF06_CPX (58.8%), CRF02_AG (35.3%), and subtype G (5.9%).

Burkina FasoVIH/sidapublié 2015Global health actioneurope_pmcdocument de 5 observations

2,21 %The overall seroprevalence rate of HIV among blood donors in Burkina Faso was 2.21%.

Burkina FasoVIH/sidapublié 2011Blood transfusion = Trasfusione del sangueeurope_pmcdocument de 9 observations

0,495 odds_ratioHIV stigma is negatively associated with HIV seropositivity in young women (OR = 0.495; 95% CI = 0.247, 0.990) in the fully adjusted model.

Burkina FasoVIH/sidapublié 2021Journal of global healthPubMeddocument de 4 observations

12,8 %The prevalence of HBV was 12.8% among HIV-1 seronegative subjects in the study population in Burkina Faso.

Burkina Fasohépatite B · VIH/sidapublié 2016BMC infectious diseaseseurope_pmcdocument de 4 observations

0 %Vertical transmission of HIV was 0.00% (0/274) among mothers under HAART.

Burkina FasoVIH/sidapublié 2015Global health actioneurope_pmcdocument de 5 observations

7,06 %L'incidence de la neuropathie périphérique était de 7,06 % chez les personnes vivant avec le VIH au Burkina Faso selon l'étude de Millogo A et al (2003).

Burkina FasoVIH/sidaobservé 2003HAL · Unilimdocument de 747 observations

5 %The prevalence of HIV drug resistance mutations (HIVDRM) is scored as low (≤ 5%) in all five study sites — Thailand, Vietnam, Burkina Faso, Côte d'Ivoire, and Senegal — for the three drug classes analyzed.

Burkina Faso · Côte d'Ivoire · SénégalVIH/sidapublié 2009AIDS Research and Human RetrovirusesOpenAlexdocument de 3 observations

8,4 %La fréquence de la neuropathie sensitive, sensitivo-motrice et polyneuropathique chez les personnes vivant avec le VIH au Burkina Faso était de 8,4 % en 2008.

Burkina Fasoneuropathie périphérique · VIH/sidaobservé 2008HAL · Unilimdocument de 747 observations

90 %La fréquence de la neuropathie chez les personnes vivant avec le VIH au Burkina Faso était de 90 % en 2007.

Burkina FasoVIH/sidaobservé 2007HAL · Unilimdocument de 747 observations

3,3 %Among 4,520 blood donors in Burkina Faso in 2009, 149 (3.30%) had serological evidence of multiple infections.

Burkina Fasohépatite B · hépatite C · syphilis · VIH/sidaobservé 2009publié 2011Blood transfusion = Trasfusione del sangueeurope_pmcdocument de 9 observations

0,54 odds_ratioThe haplotype GGT from the rs6001417, rs8177832 and rs35228531 SNPs has a protective effect against HIV-1 infection with an odds ratio of 0.54 [0.43–0.68] and p-value < 0.001.

Burkina FasoVIH/sidapublié 2016PloS oneeurope_pmcdocument de 4 observations

1,6 odds_ratioThe haplotype GGC is associated with increased risk of HIV-1 infection with an odds ratio of 1.6 [1.1–2.3] and p-value < 0.05.

Burkina FasoVIH/sidapublié 2016PloS oneeurope_pmcdocument de 4 observations

56,7 %The prevalence of HBV was 56.7% among HIV-1 positive patients in the study population in Burkina Faso.

Burkina Fasohépatite B · VIH/sidapublié 2016BMC infectious diseaseseurope_pmcdocument de 4 observations

1,75 %Vertical transmission of HIV was 1.75% (2/114) among mothers under prophylaxis.

Burkina FasoVIH/sidapublié 2015Global health actioneurope_pmcdocument de 5 observations

0,52 %There was 0.52% (2/388) overall vertical transmission of HIV in infants born to HIV-positive mothers.

Burkina FasoVIH/sidapublié 2015Global health actioneurope_pmcdocument de 5 observations

1,8 %The seroprevalence of HIV in first-time volunteer blood donors in Burkina Faso in 2009 was 1.8%.

Burkina FasoVIH/sidaobservé 2009publié 2012Tropical medicine & international health : TM & IHeurope_pmcdocument de 9 observationsDOI 10.1111/j.1365-3156.2011.02902.x

0,215 odds_ratioHigher education is associated with reduced odds of HIV seropositivity in young women (OR = 0.215; 95% CI = 0.057, 0.820).

Burkina FasoVIH/sidapublié 2021Journal of global healthPubMeddocument de 4 observations

3 270,2 per_100000Among 3,981 repeat blood donors in Burkina Faso in 2009, the incidence rate of anti-HIV-1 was 3270.2 per 100000 donations.

Burkina FasoVIH/sidaobservé 2009publié 2012Tropical medicine & international health : TM & IHeurope_pmcdocument de 9 observationsDOI 10.1111/j.1365-3156.2011.02902.x

29,82 %Among 4,520 blood donors in Burkina Faso in 2009, 1,348 (29.82%) were infected with at least one pathogen.

Burkina Fasohépatite B · hépatite C · syphilis · VIH/sidaobservé 2009publié 2011Blood transfusion = Trasfusione del sangueeurope_pmcdocument de 9 observations

The prevalence of HIV seropositivity among young women is higher than for men of the same age in all included Demographic and Health Surveys except for the Burkina Faso DHS.

Burkina FasoVIH/sidapublié 2021Journal of global healthPubMeddocument de 4 observations

8,4 %La fréquence de la neuropathie périphérique était de 8,4 % chez les personnes vivant avec le VIH au Burkina Faso selon l'étude de Millogo A et al (2008).

Burkina FasoVIH/sidaobservé 2008HAL · Unilimdocument de 747 observations

12,26 %In this study, 12.26% (394/3,215) of the pregnant women were diagnosed HIV positive.

Burkina FasoVIH/sidapublié 2015Global health actioneurope_pmcdocument de 5 observations

0,7 %The HIV prevalence rate is 0.7% in Burkina Faso.

Burkina FasoVIH/sidaHAL · Unilimdocument de 97 observations

5,21 odds_ratioThe haplotype CGC is associated with increased risk of HIV-1 infection with an odds ratio of 5.21 [2.4–11.3] and p-value < 0.001.

Burkina FasoVIH/sidapublié 2016PloS oneeurope_pmcdocument de 4 observations

Chaque ligne mène à son document source. Le nombre indiqué est celui des observations VALIDÉES qu'il porte, jamais celui des observations extraites : les deux diffèrent sur la plupart des documents. L'extrait exact du texte source n'est pas publié, par contrainte de droit d'auteur.